Security Snapshot

Guardant Health, Inc. - Common Stock (GH) Institutional Ownership

CUSIP: 40131M109

13F Institutional Holders and Ownership History from Q4 2018 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

490

Shares (Excl. Options)

131,043,915

Price

$102.14

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
GH on Nasdaq
Shares outstanding
123,850,680
Price per share
$92.37
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
131,043,915
Total reported value
$13,383,536,666
% of total 13F portfolios
0.01%
Share change
+7,567,922
Value change
+$814,289,027
Number of holders
490
Price from insider filings
$92.37
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • GH - Guardant Health, Inc. - Common Stock is tracked under CUSIP 40131M109.
  • 490 institutions reported positions in Q4 2025.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 490 to 42 between Q4 2025 and Q1 2026.
  • Reported value moved from $13,383,536,666 to $14,749,543.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 490 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 40131M109?
CUSIP 40131M109 identifies GH - Guardant Health, Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Guardant Health, Inc. - Common Stock (GH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.5% $460,074,314 9,288,801 BlackRock, Inc. 31 Mar 2025
Deep Track Capital, LP 4.4% $269,627,501 5,443,721 Deep Track Capital, LP 31 Mar 2025
CADIAN CAPITAL MANAGEMENT, LP 4.2% $258,624,114 5,221,565 Cadian Capital Management, LP 31 Dec 2024
WELLINGTON MANAGEMENT GROUP LLP 3.9% $240,233,923 4,850,271 Wellington Management Group LLP 31 Dec 2024

As of 31 Dec 2025, 490 institutional investors reported holding 131,043,915 shares of Guardant Health, Inc. - Common Stock (GH). This represents 106% of the company’s total 123,850,680 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Guardant Health, Inc. - Common Stock (GH) together control 69% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.8% 12,160,768 +2.1% 0.02% $1,242,100,844
BlackRock, Inc. 9.1% 11,317,714 -0.98% 0.02% $1,155,991,262
PRICE T ROWE ASSOCIATES INC /MD/ 4.6% 5,636,078 +34% 0.06% $575,670,000
Invesco Ltd. 4.3% 5,315,934 +7.8% 0.08% $542,969,482
BAILLIE GIFFORD & CO 3.9% 4,890,026 -4.6% 0.42% $499,467,256
Capital International Investors 2.8% 3,528,656 -25% 0.06% $360,416,924
FRANKLIN RESOURCES INC 2.7% 3,361,547 +15% 0.08% $343,348,455
GEODE CAPITAL MANAGEMENT, LLC 2.6% 3,213,657 +9.4% 0.02% $328,296,726
Deep Track Capital, LP 2.3% 2,800,000 -33% 6.5% $285,992,000
STATE STREET CORP 2.3% 2,795,727 +0.29% 0.01% $285,555,556
GOLDMAN SACHS GROUP INC 2.1% 2,627,709 +74% 0.04% $268,394,156
EVENTIDE ASSET MANAGEMENT, LLC 2% 2,511,091 -24% 4% $256,454,805
FULLER & THALER ASSET MANAGEMENT, INC. 2% 2,441,730 +3% 0.84% $249,398,349
FMR LLC 1.9% 2,396,433 +191% 0.01% $244,771,750
TWO SIGMA ADVISERS, LP 1.9% 2,382,300 +13% 0.47% $243,328,122
TWO SIGMA INVESTMENTS, LP 1.8% 2,171,903 +20% 0.33% $221,838,172
Driehaus Capital Management LLC 1.7% 2,143,193 -0.42% 1.5% $218,905,733
FEDERATED HERMES, INC. 1.6% 2,031,562 +14% 0.35% $207,503,743
LORD, ABBETT & CO. LLC 1.6% 1,988,983 +31% 0.62% $203,155,000
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 1.5% 1,915,581 -15% 0.04% $195,657,444
ALLIANCEBERNSTEIN L.P. 1.5% 1,901,308 +1263% 0.06% $194,199,599
UBS Group AG 1.4% 1,710,169 +17% 0.03% $174,676,662
Point72 Asset Management, L.P. 1.2% 1,499,169 +1364% 0.24% $153,125,122
RTW INVESTMENTS, LP 1.2% 1,481,033 0% 1.5% $151,272,711
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.2% 1,457,676 +3% 0.02% $148,887,039

Institutional Holders of Guardant Health, Inc. - Common Stock (GH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 161,979 $14,749,543 -$30,370,058 $92.37 42
2025 Q4 131,043,915 $13,383,536,666 +$814,289,027 $102.14 490
2025 Q3 122,493,323 $7,653,044,062 -$62,866,800 $62.48 388
2025 Q2 124,295,969 $6,467,826,507 +$330,760,770 $52.04 359
2025 Q1 118,497,703 $5,048,168,027 +$16,046,986 $42.60 336
2024 Q4 119,495,658 $3,649,677,643 -$152,886,448 $30.55 294
2024 Q3 124,539,664 $2,855,453,478 +$192,800,636 $22.94 264
2024 Q2 114,848,348 $3,316,872,682 +$179,592,491 $28.88 274
2024 Q1 111,383,571 $2,296,334,142 -$29,707,645 $20.63 252
2023 Q4 110,309,454 $2,983,894,470 +$45,961,733 $27.05 289
2023 Q3 108,297,993 $3,210,080,906 -$83,646,730 $29.64 289
2023 Q2 110,144,879 $3,943,258,288 +$694,610,966 $35.80 293
2023 Q1 92,579,337 $2,168,850,990 -$17,004,713 $23.44 271
2022 Q4 94,289,245 $2,564,763,814 -$199,503,944 $27.20 280
2022 Q3 94,962,606 $5,108,852,818 +$162,272,236 $53.83 310
2022 Q2 92,768,225 $3,745,003,930 -$39,996,274 $40.34 310
2022 Q1 92,443,619 $6,110,748,734 -$81,915,249 $66.24 335
2021 Q4 92,085,897 $9,209,883,362 -$251,467,115 $100.02 379
2021 Q3 94,130,065 $11,765,302,482 +$583,304,963 $125.01 365
2021 Q2 89,577,134 $11,124,047,648 -$275,498,694 $124.19 410
2021 Q1 91,351,911 $13,941,648,366 +$681,296,473 $152.65 410
2020 Q4 87,374,557 $11,260,127,731 +$219,249,861 $128.88 399
2020 Q3 85,443,260 $9,550,543,816 +$176,117,596 $111.78 341
2020 Q2 84,323,375 $6,840,933,865 +$491,051,528 $81.13 311
2020 Q1 78,329,707 $5,451,350,483 +$31,071,063 $69.60 281
2019 Q4 77,055,101 $6,021,065,515 +$259,064,552 $78.14 261
2019 Q3 73,811,798 $4,711,407,821 -$154,907,012 $63.83 230
2019 Q2 75,988,996 $6,559,989,770 +$1,412,721,312 $86.33 214
2019 Q1 60,292,447 $4,622,332,723 +$11,801,888 $76.70 144
2018 Q4 61,703,860 $2,318,551,779 +$2,050,102,770 $37.59 87